Cargando…
A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer
BACKGROUND: Many scientific papers are published each year and substantial resources are spent to develop biomarker-based tests for precision oncology. However, only a handful of tests is currently used in daily clinical practice, since development is challenging. In this situation, the application...
Autores principales: | Sollfrank, L, Linn, SC, Hauptmann, M, Jóźwiak, K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10308726/ https://www.ncbi.nlm.nih.gov/pubmed/37386356 http://dx.doi.org/10.1186/s12874-023-01982-w |
Ejemplares similares
-
Correction: A scoping review of statistical methods in studies of biomarker-related treatment heterogeneity for breast cancer
por: Sollfrank, L, et al.
Publicado: (2023) -
Statistical analysis of longitudinal data on tumour growth in mice experiments
por: Zavrakidis, Ioannis, et al.
Publicado: (2020) -
Predictive approaches to heterogeneous treatment effects: a scoping review
por: Rekkas, Alexandros, et al.
Publicado: (2020) -
Adjuvant Aromatase Inhibitors or Tamoxifen Following Chemotherapy for Perimenopausal Breast Cancer Patients
por: Dackus, Gwen M H E, et al.
Publicado: (2021) -
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer
por: Dackus, Gwen M. H. E., et al.
Publicado: (2020)